Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 179 entries
Sorted by: Best Match Show Resources per page
Three-Cornered Hat and Groslambert Covariance: A First Attempt to Assess the Uncertainty Domains.

IEEE transactions on ultrasonics, ferroelectrics, and frequency control

Vernotte F, Lantz E.
PMID: 30596574
IEEE Trans Ultrason Ferroelectr Freq Control. 2019 Mar;66(3):643-653. doi: 10.1109/TUFFC.2018.2889703. Epub 2018 Dec 25.

The three-cornered hat method and the Groslambert covariance are very often used to estimate the frequency stability of each individual oscillator in a set of three oscillators by comparing them in pairs. However, no rigorous method to assess the...

Cite
Vernotte F, Lantz E. Three-Cornered Hat and Groslambert Covariance: A First Attempt to Assess the Uncertainty Domains. IEEE Trans Ultrason Ferroelectr Freq Control. 2018;66(3):643-653doi: 10.1109/TUFFC.2018.2889703.
Vernotte, F., & Lantz, E. (2019). Three-Cornered Hat and Groslambert Covariance: A First Attempt to Assess the Uncertainty Domains. IEEE transactions on ultrasonics, ferroelectrics, and frequency control, 66(3), 643-653. https://doi.org/10.1109/TUFFC.2018.2889703
Vernotte, Francois, and Lantz, Eric. "Three-Cornered Hat and Groslambert Covariance: A First Attempt to Assess the Uncertainty Domains." IEEE transactions on ultrasonics, ferroelectrics, and frequency control vol. 66,3 (2019): 643-653. doi: https://doi.org/10.1109/TUFFC.2018.2889703
Vernotte F, Lantz E. Three-Cornered Hat and Groslambert Covariance: A First Attempt to Assess the Uncertainty Domains. IEEE Trans Ultrason Ferroelectr Freq Control. 2019 Mar;66(3):643-653. doi: 10.1109/TUFFC.2018.2889703. Epub 2018 Dec 25. PMID: 30596574.
Copy Download .nbib Format: NLM
Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways.

Frontiers in pharmacology

Miner K, Labitzke K, Liu B, Wang P, Henckels K, Gaida K, Elliott R, Chen JJ, Liu L, Leith A, Trueblood E, Hensley K, Xia XZ, Homann O, Bennett B, Fiorino M, Whoriskey J, Yu G, Escobar S, Wong M, Born TL, Budelsky A, Comeau M, Smith D, Phillips J, Johnston JA, McGivern JG, Weikl K, Powers D, Kunzelmann K, Mohn D, Hochheimer A, Sullivan JK.
PMID: 30837866
Front Pharmacol. 2019 Feb 14;10:51. doi: 10.3389/fphar.2019.00051. eCollection 2019.

There is an unmet need in severe asthma where approximately 40% of patients exhibit poor β-agonist responsiveness, suffer daily symptoms and show frequent exacerbations. Antagonists of the Ca

Cite
Miner K, Labitzke K, Liu B, et al. Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways. Front Pharmacol. 2019;10:51doi: 10.3389/fphar.2019.00051.
Miner, K., Labitzke, K., Liu, B., Wang, P., Henckels, K., Gaida, K., Elliott, R., Chen, J. J., Liu, L., Leith, A., Trueblood, E., Hensley, K., Xia, X. Z., Homann, O., Bennett, B., Fiorino, M., Whoriskey, J., Yu, G., Escobar, S., Wong, M., Born, T. L., Budelsky, A., Comeau, M., Smith, D., Phillips, J., Johnston, J. A., McGivern, J. G., Weikl, K., Powers, D., Kunzelmann, K., Mohn, D., Hochheimer, A., & Sullivan, J. K. (2019). Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways. Frontiers in pharmacology, 1051. https://doi.org/10.3389/fphar.2019.00051
Miner, Kent, et al. "Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways." Frontiers in pharmacology vol. 10 (2019): 51. doi: https://doi.org/10.3389/fphar.2019.00051
Miner K, Labitzke K, Liu B, Wang P, Henckels K, Gaida K, Elliott R, Chen JJ, Liu L, Leith A, Trueblood E, Hensley K, Xia XZ, Homann O, Bennett B, Fiorino M, Whoriskey J, Yu G, Escobar S, Wong M, Born TL, Budelsky A, Comeau M, Smith D, Phillips J, Johnston JA, McGivern JG, Weikl K, Powers D, Kunzelmann K, Mohn D, Hochheimer A, Sullivan JK. Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways. Front Pharmacol. 2019 Feb 14;10:51. doi: 10.3389/fphar.2019.00051. eCollection 2019. PMID: 30837866; PMCID: PMC6382696.
Copy Download .nbib Format: NLM
Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patients.

Pituitary

Thakur JD, Corlin A, Mallari RJ, Yawitz S, Eisenberg A, Sivakumar W, Griffiths C, Carrau RL, Rettinger S, Cohan P, Krauss H, Araque KA, Barkhoudarian G, Kelly DF.
PMID: 34215990
Pituitary. 2021 Dec;24(6):930-942. doi: 10.1007/s11102-021-01167-y. Epub 2021 Jul 02.

PURPOSE: To evaluate the impact of using consistent complication-avoidance protocols in patients undergoing endoscopic pituitary adenoma surgery including techniques for avoiding anosmia, epistaxis, carotid artery injury, hypopituitarism, cerebrospinal fluid leaks and meningitis.METHODS: All patients undergoing endoscopic adenoma resection from...

Cite
Thakur JD, Corlin A, Mallari RJ, et al. Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patients. Pituitary. 2021;24(6):930-942doi: 10.1007/s11102-021-01167-y.
Thakur, J. D., Corlin, A., Mallari, R. J., Yawitz, S., Eisenberg, A., Sivakumar, W., Griffiths, C., Carrau, R. L., Rettinger, S., Cohan, P., Krauss, H., Araque, K. A., Barkhoudarian, G., & Kelly, D. F. (2021). Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patients. Pituitary, 24(6), 930-942. https://doi.org/10.1007/s11102-021-01167-y
Thakur, Jai Deep, et al. "Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patients." Pituitary vol. 24,6 (2021): 930-942. doi: https://doi.org/10.1007/s11102-021-01167-y
Thakur JD, Corlin A, Mallari RJ, Yawitz S, Eisenberg A, Sivakumar W, Griffiths C, Carrau RL, Rettinger S, Cohan P, Krauss H, Araque KA, Barkhoudarian G, Kelly DF. Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patients. Pituitary. 2021 Dec;24(6):930-942. doi: 10.1007/s11102-021-01167-y. Epub 2021 Jul 02. PMID: 34215990; PMCID: PMC8252985.
Copy Download .nbib Format: NLM
Regulation of ubiquitin and ubiquitin-like modifiers by phosphorylation.

The FEBS journal

Hepowit NL, Kolbe CC, Zelle SR, Latz E, MacGurn JA.
PMID: 34214249
FEBS J. 2021 Jul 02; doi: 10.1111/febs.16101. Epub 2021 Jul 02.

The regulatory influence of ubiquitin is vast, encompassing all cellular processes, by virtue of its central roles in protein degradation, membrane trafficking, and cell signaling. But how does ubiquitin, a 76 amino acid peptide, carry out such diverse, complex...

Cite
Hepowit NL, Kolbe CC, Zelle SR, et al. Regulation of ubiquitin and ubiquitin-like modifiers by phosphorylation. FEBS J. 2021;doi: 10.1111/febs.16101.
Hepowit, N. L., Kolbe, C. C., Zelle, S. R., Latz, E., & MacGurn, J. A. (2021). Regulation of ubiquitin and ubiquitin-like modifiers by phosphorylation. The FEBS journal, . https://doi.org/10.1111/febs.16101
Hepowit, Nathaniel L, et al. "Regulation of ubiquitin and ubiquitin-like modifiers by phosphorylation." The FEBS journal vol. (2021). doi: https://doi.org/10.1111/febs.16101
Hepowit NL, Kolbe CC, Zelle SR, Latz E, MacGurn JA. Regulation of ubiquitin and ubiquitin-like modifiers by phosphorylation. FEBS J. 2021 Jul 02; doi: 10.1111/febs.16101. Epub 2021 Jul 02. PMID: 34214249.
Copy Download .nbib Format: NLM
Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Lawitz EJ, Bhandari BR, Ruane PJ, Kohli A, Harting E, Ding D, Chuang JC, Huss RS, Chung C, Myers RP, Loomba R.
PMID: 34999207
Clin Gastroenterol Hepatol. 2022 Jan 06; doi: 10.1016/j.cgh.2021.12.044. Epub 2022 Jan 06.

BACKGROUND & AIMS: Patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH) are at high risk of morbidity and mortality. We previously found that a combination of the farnesoid X receptor agonist cilofexor (CILO) and the acetyl-CoA carboxylase (ACC)...

Cite
Lawitz EJ, Bhandari BR, Ruane PJ, et al. Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat. Clin Gastroenterol Hepatol. 2022;doi: 10.1016/j.cgh.2021.12.044.
Lawitz, E. J., Bhandari, B. R., Ruane, P. J., Kohli, A., Harting, E., Ding, D., Chuang, J. C., Huss, R. S., Chung, C., Myers, R. P., & Loomba, R. (2022). Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, . https://doi.org/10.1016/j.cgh.2021.12.044
Lawitz, Eric J, et al. "Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. (2022). doi: https://doi.org/10.1016/j.cgh.2021.12.044
Lawitz EJ, Bhandari BR, Ruane PJ, Kohli A, Harting E, Ding D, Chuang JC, Huss RS, Chung C, Myers RP, Loomba R. Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat. Clin Gastroenterol Hepatol. 2022 Jan 06; doi: 10.1016/j.cgh.2021.12.044. Epub 2022 Jan 06. PMID: 34999207.
Copy Download .nbib Format: NLM
Inflammasome-induced extracellular vesicles harbour distinct RNA signatures and alter bystander macrophage responses.

Journal of extracellular vesicles

Budden CF, Gearing LJ, Kaiser R, Standke L, Hertzog PJ, Latz E.
PMID: 34377374
J Extracell Vesicles. 2021 Aug;10(10):e12127. doi: 10.1002/jev2.12127. Epub 2021 Aug 02.

Infectious organisms and damage of cells can activate inflammasomes, which mediate tissue inflammation and adaptive immunity. These mechanisms evolved to curb the spread of microbes and to induce repair of the damaged tissue. Chronic activation of inflammasomes, however, contributes...

Cite
Budden CF, Gearing LJ, Kaiser R, et al. Inflammasome-induced extracellular vesicles harbour distinct RNA signatures and alter bystander macrophage responses. J Extracell Vesicles. 2021;10(10):e12127doi: 10.1002/jev2.12127.
Budden, C. F., Gearing, L. J., Kaiser, R., Standke, L., Hertzog, P. J., & Latz, E. (2021). Inflammasome-induced extracellular vesicles harbour distinct RNA signatures and alter bystander macrophage responses. Journal of extracellular vesicles, 10(10), e12127. https://doi.org/10.1002/jev2.12127
Budden, Christina F, et al. "Inflammasome-induced extracellular vesicles harbour distinct RNA signatures and alter bystander macrophage responses." Journal of extracellular vesicles vol. 10,10 (2021): e12127. doi: https://doi.org/10.1002/jev2.12127
Budden CF, Gearing LJ, Kaiser R, Standke L, Hertzog PJ, Latz E. Inflammasome-induced extracellular vesicles harbour distinct RNA signatures and alter bystander macrophage responses. J Extracell Vesicles. 2021 Aug;10(10):e12127. doi: 10.1002/jev2.12127. Epub 2021 Aug 02. PMID: 34377374; PMCID: PMC8329986.
Copy Download .nbib Format: NLM
BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial.

Hepatology (Baltimore, Md.)

Lawitz EJ, Shevell DE, Tirucherai GS, Du S, Chen W, Kavita U, Coste A, Poordad F, Karsdal M, Nielsen M, Goodman Z, Charles ED.
PMID: 34605045
Hepatology. 2021 Oct 04; doi: 10.1002/hep.32181. Epub 2021 Oct 04.

BACKGROUND AND AIMS: Hepatic fibrosis secondary to HCV infection can lead to cirrhosis and hepatic decompensation. Sustained virologic response (SVR) is possible with direct-acting antiviral drug regimens; however, patients with advanced fibrosis have an increased risk for HCC. Heat...

Cite
Lawitz EJ, Shevell DE, Tirucherai GS, et al. BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial. Hepatology. 2021;doi: 10.1002/hep.32181.
Lawitz, E. J., Shevell, D. E., Tirucherai, G. S., Du, S., Chen, W., Kavita, U., Coste, A., Poordad, F., Karsdal, M., Nielsen, M., Goodman, Z., & Charles, E. D. (2021). BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial. Hepatology (Baltimore, Md.), . https://doi.org/10.1002/hep.32181
Lawitz, Eric J, et al. "BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial." Hepatology (Baltimore, Md.) vol. (2021). doi: https://doi.org/10.1002/hep.32181
Lawitz EJ, Shevell DE, Tirucherai GS, Du S, Chen W, Kavita U, Coste A, Poordad F, Karsdal M, Nielsen M, Goodman Z, Charles ED. BMS-986263 in patients with advanced hepatic fibrosis: 36-week results from a randomized, placebo-controlled phase 2 trial. Hepatology. 2021 Oct 04; doi: 10.1002/hep.32181. Epub 2021 Oct 04. PMID: 34605045.
Copy Download .nbib Format: NLM
TeamSTEPPS Curricular-Wide Integration: Baccalaureate Nursing Students' Knowledge, Attitudes, and Perceptions.

Nurse educator

Ross JG, Latz E, Meakim CH, Mariani B.
PMID: 33767080
Nurse Educ. 2021 Nov-Dec 01;46(6):355-360. doi: 10.1097/NNE.0000000000000999.

BACKGROUND: To promote safe patient care, nurses must work collaboratively with members of the interprofessional health care team.PURPOSE: The purposes of this study were to explore the effect of a curricular-wide integration of TeamSTEPPS training on baccalaureate nursing students'...

Cite
Ross JG, Latz E, Meakim CH, et al. TeamSTEPPS Curricular-Wide Integration: Baccalaureate Nursing Students' Knowledge, Attitudes, and Perceptions. Nurse Educ. 2021;46(6):355-360doi: 10.1097/NNE.0000000000000999.
Ross, J. G., Latz, E., Meakim, C. H., & Mariani, B. (2021). TeamSTEPPS Curricular-Wide Integration: Baccalaureate Nursing Students' Knowledge, Attitudes, and Perceptions. Nurse educator, 46(6), 355-360. https://doi.org/10.1097/NNE.0000000000000999
Ross, Jennifer Gunberg, et al. "TeamSTEPPS Curricular-Wide Integration: Baccalaureate Nursing Students' Knowledge, Attitudes, and Perceptions." Nurse educator vol. 46,6 (2021): 355-360. doi: https://doi.org/10.1097/NNE.0000000000000999
Ross JG, Latz E, Meakim CH, Mariani B. TeamSTEPPS Curricular-Wide Integration: Baccalaureate Nursing Students' Knowledge, Attitudes, and Perceptions. Nurse Educ. 2021 Nov-Dec 01;46(6):355-360. doi: 10.1097/NNE.0000000000000999. PMID: 33767080.
Copy Download .nbib Format: NLM
Necroptosis, pyroptosis and apoptosis: an intricate game of cell death.

Cellular & molecular immunology

Bertheloot D, Latz E, Franklin BS.
PMID: 33785842
Cell Mol Immunol. 2021 May;18(5):1106-1121. doi: 10.1038/s41423-020-00630-3. Epub 2021 Mar 30.

Cell death is a fundamental physiological process in all living organisms. Its roles extend from embryonic development, organ maintenance, and aging to the coordination of immune responses and autoimmunity. In recent years, our understanding of the mechanisms orchestrating cellular...

Cite
Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021;18(5):1106-1121doi: 10.1038/s41423-020-00630-3.
Bertheloot, D., Latz, E., & Franklin, B. S. (2021). Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cellular & molecular immunology, 18(5), 1106-1121. https://doi.org/10.1038/s41423-020-00630-3
Bertheloot, Damien, et al. "Necroptosis, pyroptosis and apoptosis: an intricate game of cell death." Cellular & molecular immunology vol. 18,5 (2021): 1106-1121. doi: https://doi.org/10.1038/s41423-020-00630-3
Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021 May;18(5):1106-1121. doi: 10.1038/s41423-020-00630-3. Epub 2021 Mar 30. PMID: 33785842; PMCID: PMC8008022.
Copy Download .nbib Format: NLM
The multifaceted therapeutic value of targeting ATP-citrate lyase in atherosclerosis.

Trends in molecular medicine

Verberk SGS, Kuiper KL, Lauterbach MA, Latz E, Van den Bossche J.
PMID: 34635427
Trends Mol Med. 2021 Dec;27(12):1095-1105. doi: 10.1016/j.molmed.2021.09.004. Epub 2021 Oct 08.

ATP-citrate lyase (Acly) is the target of the new class low-density lipoprotein-cholesterol (LDL-C)-lowering drug bempedoic acid (BA). Acly is a key metabolic enzyme synthesizing acetyl-CoA as the building block of cholesterol and fatty acids. Treatment with BA lowers circulating...

Cite
Verberk SGS, Kuiper KL, Lauterbach MA, et al. The multifaceted therapeutic value of targeting ATP-citrate lyase in atherosclerosis. Trends Mol Med. 2021;27(12):1095-1105doi: 10.1016/j.molmed.2021.09.004.
Verberk, S. G. S., Kuiper, K. L., Lauterbach, M. A., Latz, E., & Van den Bossche, J. (2021). The multifaceted therapeutic value of targeting ATP-citrate lyase in atherosclerosis. Trends in molecular medicine, 27(12), 1095-1105. https://doi.org/10.1016/j.molmed.2021.09.004
Verberk, Sanne G S, et al. "The multifaceted therapeutic value of targeting ATP-citrate lyase in atherosclerosis." Trends in molecular medicine vol. 27,12 (2021): 1095-1105. doi: https://doi.org/10.1016/j.molmed.2021.09.004
Verberk SGS, Kuiper KL, Lauterbach MA, Latz E, Van den Bossche J. The multifaceted therapeutic value of targeting ATP-citrate lyase in atherosclerosis. Trends Mol Med. 2021 Dec;27(12):1095-1105. doi: 10.1016/j.molmed.2021.09.004. Epub 2021 Oct 08. PMID: 34635427.
Copy Download .nbib Format: NLM
Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group.

International journal of cancer

Lavit E, Aldea M, Piperno-Neumann S, Firmin N, Italiano A, Isambert N, Kurtz JE, Delcambre C, Lebrun V, Soibinet-Oudot P, Chevreau C, Bompas E, Le Maignan C, Boudou-Rouquette P, Le Cesne A, Mancini J, Blay JY, Duffaud F.
PMID: 34562271
Int J Cancer. 2021 Sep 25; doi: 10.1002/ijc.33823. Epub 2021 Sep 25.

Treatment options for metastatic osteosarcomas are scarce. Following failure of standard first line therapy, patients who relapse present a challenging treatment dilemma, and have a poor prognosis. Surgical removal of all metastases is essential. A retrospective analysis of patients...

Cite
Lavit E, Aldea M, Piperno-Neumann S, et al. Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group. Int J Cancer. 2021;doi: 10.1002/ijc.33823.
Lavit, E., Aldea, M., Piperno-Neumann, S., Firmin, N., Italiano, A., Isambert, N., Kurtz, J. E., Delcambre, C., Lebrun, V., Soibinet-Oudot, P., Chevreau, C., Bompas, E., Le Maignan, C., Boudou-Rouquette, P., Le Cesne, A., Mancini, J., Blay, J. Y., & Duffaud, F. (2021). Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group. International journal of cancer, . https://doi.org/10.1002/ijc.33823
Lavit, Elise, et al. "Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group." International journal of cancer vol. (2021). doi: https://doi.org/10.1002/ijc.33823
Lavit E, Aldea M, Piperno-Neumann S, Firmin N, Italiano A, Isambert N, Kurtz JE, Delcambre C, Lebrun V, Soibinet-Oudot P, Chevreau C, Bompas E, Le Maignan C, Boudou-Rouquette P, Le Cesne A, Mancini J, Blay JY, Duffaud F. Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group. Int J Cancer. 2021 Sep 25; doi: 10.1002/ijc.33823. Epub 2021 Sep 25. PMID: 34562271.
Copy Download .nbib Format: NLM
Author Correction: Trained immunity, tolerance, priming and differentiation: distinct immunological processes.

Nature immunology

Divangahi M, Aaby P, Khader SA, Barreiro LB, Bekkering S, Chavakis T, van Crevel R, Curtis N, DiNardo AR, Dominguez-Andres J, Duivenvoorden R, Fanucchi S, Fayad Z, Fuchs E, Hamon M, Jeffrey KL, Khan N, Joosten LAB, Kaufmann E, Latz E, Matarese G, van der Meer JWM, Mhlanga M, Moorlag SJCFM, Mulder WJM, Naik S, Novakovic B, O'Neill L, Ochando J, Ozato K, Riksen NP, Sauerwein R, Sherwood ER, Schlitzer A, Schultze JL, Sieweke MH, Benn CS, Stunnenberg H, Sun J, van de Veerdonk FL, Weis S, Williams DL, Xavier R, Netea MG.
PMID: 34017127
Nat Immunol. 2021 Jul;22(7):928. doi: 10.1038/s41590-021-00960-y.

No abstract available.

Cite
Divangahi M, Aaby P, Khader SA, et al. Author Correction: Trained immunity, tolerance, priming and differentiation: distinct immunological processes. Nat Immunol. 2021;22(7):928doi: 10.1038/s41590-021-00960-y.
Divangahi, M., Aaby, P., Khader, S. A., Barreiro, L. B., Bekkering, S., Chavakis, T., van Crevel, R., Curtis, N., DiNardo, A. R., Dominguez-Andres, J., Duivenvoorden, R., Fanucchi, S., Fayad, Z., Fuchs, E., Hamon, M., Jeffrey, K. L., Khan, N., Joosten, L. A. B., Kaufmann, E., Latz, E., Matarese, G., van der Meer, J. W. M., Mhlanga, M., Moorlag, S. J. C. F. M., Mulder, W. J. M., Naik, S., Novakovic, B., O'Neill, L., Ochando, J., Ozato, K., Riksen, N. P., Sauerwein, R., Sherwood, E. R., Schlitzer, A., Schultze, J. L., Sieweke, M. H., Benn, C. S., Stunnenberg, H., Sun, J., van de Veerdonk, F. L., Weis, S., Williams, D. L., Xavier, R., & Netea, M. G. (2021). Author Correction: Trained immunity, tolerance, priming and differentiation: distinct immunological processes. Nature immunology, 22(7), 928. https://doi.org/10.1038/s41590-021-00960-y
Divangahi, Maziar, et al. "Author Correction: Trained immunity, tolerance, priming and differentiation: distinct immunological processes." Nature immunology vol. 22,7 (2021): 928. doi: https://doi.org/10.1038/s41590-021-00960-y
Divangahi M, Aaby P, Khader SA, Barreiro LB, Bekkering S, Chavakis T, van Crevel R, Curtis N, DiNardo AR, Dominguez-Andres J, Duivenvoorden R, Fanucchi S, Fayad Z, Fuchs E, Hamon M, Jeffrey KL, Khan N, Joosten LAB, Kaufmann E, Latz E, Matarese G, van der Meer JWM, Mhlanga M, Moorlag SJCFM, Mulder WJM, Naik S, Novakovic B, O'Neill L, Ochando J, Ozato K, Riksen NP, Sauerwein R, Sherwood ER, Schlitzer A, Schultze JL, Sieweke MH, Benn CS, Stunnenberg H, Sun J, van de Veerdonk FL, Weis S, Williams DL, Xavier R, Netea MG. Author Correction: Trained immunity, tolerance, priming and differentiation: distinct immunological processes. Nat Immunol. 2021 Jul;22(7):928. doi: 10.1038/s41590-021-00960-y. PMID: 34017127.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 179 entries